MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Apricus Biosciences Company Profile (NASDAQ:APRI)

Consensus Ratings for Apricus Biosciences (NASDAQ:APRI) (?)
Ratings Breakdown: 3 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $2.32 (479.17% upside)

Analysts' Ratings History for Apricus Biosciences (NASDAQ:APRI)
Show:
DateFirmActionRatingPrice TargetActions
3/15/2016Taglich BrothersLower Price TargetSpeculative Buy$4.25 -> $2.95View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016Dawson JamesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2015Sterne Agee CRTDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Roth CapitalDowngradeBuy -> Neutral$1.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015Ascendiant Capital MarketsInitiated CoverageBuy$2.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2014Cantor FitzgeraldDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/31/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha